Related references
Note: Only part of the references are listed.Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration
Matti Karvanen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Characterization of the Polymyxin B Resistome of Pseudomonas aeruginosa
Luca Fernandez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis
Ana M. Sandri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Identification of Hopanoid Biosynthesis Genes Involved in Polymyxin Resistance in Burkholderia multivorans
Rebecca J. Malott et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Colistin-Resistant, Lipopolysaccharide-Deficient Acinetobacter baumannii Responds to Lipopolysaccharide Loss through Increased Expression of Genes Involved in the Synthesis and Transport of Lipoproteins, Phospholipids, and Poly-beta-1,6-N-Acetylglucosamine
Rebekah Henry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Rapid Killing of Acinetobacter baumannii by Polymyxins Is Mediated by a Hydroxyl Radical Death Pathway
Timothy R. Sampson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Two-Component System CprRS Senses Cationic Peptides and Triggers Adaptive Resistance in Pseudomonas aeruginosa Independently of ParRS
Luca Fernandez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vivo Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection
Wang Hengzhuang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?
Phillip J. Bergen et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study
Nikolaos Markou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy
Christine J. Kubin et al.
JOURNAL OF INFECTION (2012)
Activity of Polymyxin B and the Novel Polymyxin Analogue CB-182,804 Against Contemporary Gram-Negative Pathogens in New York City
John Quale et al.
MICROBIAL DRUG RESISTANCE (2012)
Design, synthesis, and evaluation of a new fluorescent probe for measuring polymyxin-lipopolysaccharide binding interactions
Rachel L. Soon et al.
ANALYTICAL BIOCHEMISTRY (2011)
Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The pmrCAB Operon Mediates Polymyxin Resistance in Acinetobacter baumannii ATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A
Luis A. Arroyo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Analysis of the Networks Controlling the Antimicrobial-Peptide-Dependent Induction of Klebsiella pneumoniae Virulence Factors
Enrique Llobet et al.
INFECTION AND IMMUNITY (2011)
Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)
Ana C. Gales et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Metallo-β-lactamases: a last frontier for β-lactams?
Giuseppe Cornaglia et al.
LANCET INFECTIOUS DISEASES (2011)
A two-tier model of polymyxin B resistance in Burkholderia cenocepacia
Slade A. Loutet et al.
ENVIRONMENTAL MICROBIOLOGY REPORTS (2011)
Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia
Slade A. Loutet et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2011)
Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence
Emma Padilla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models
Rajesh V. Dudhani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Characterization of UDP-Glucose Dehydrogenase and UDP-Glucose Pyrophosphorylase Mutants of Proteus mirabilis: Defectiveness in Polymyxin B Resistance, Swarming, and Virulence
Sin-Sien Jiang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Adaptive Resistance to the Last Hope Antibiotics Polymyxin B and Colistin in Pseudomonas aeruginosa Is Mediated by the Novel Two-Component Regulatory System ParR-ParS
Lucia Fernandez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
Jennifer H. Moffatt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The 10 x '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
David N. Gilbert et al.
CLINICAL INFECTIOUS DISEASES (2010)
Removal of colistin during intermittent haemodialysis in two critically ill patients
Sandrine Marchand et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
Rajesh V. Dudhani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Structure-Activity Relationships of Polymyxin Antibiotics
Tony Velkov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Karthikeyan K. Kumarasamy et al.
LANCET INFECTIOUS DISEASES (2010)
Different effects of transcriptional regulators MarA, SoxS and Rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Rob-dependent CAMP induction of the marRAB operon
Douglas M. Warner et al.
MICROBIOLOGY-SGM (2010)
Klebsiella pneumoniae OmpA Confers Resistance to Antimicrobial Peptides
Enrique Llobet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Characterization of a New Metallo-beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
Dongeun Yong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Development of Des-Fatty Acyl-Polymyxin B Decapeptide Analogs with Pseudomonas aeruginosa-Specific Antimicrobial Activity
Naoko Katsuma et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2009)
Contribution of Each Amino Acid Residue in Polymyxin B3 to Antimicrobial and Lipopolysaccharide Binding Activity
Kazushi Kanazawa et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2009)
Colistin in the 21st century
Roger L. Nation et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2009)
Polymyxin B Identified as an Inhibitor of Alternative NADH Dehydrogenase and Malate: Quinone Oxidoreductase from the Gram-positive Bacterium Mycobacterium smegmatis
Tatsushi Mogi et al.
JOURNAL OF BIOCHEMISTRY (2009)
Interactions of Lipopolysaccharide and Polymyxin Studied by NMR Spectroscopy
Jiri Mares et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme
Wing Yau et al.
JOURNAL OF INFECTION (2009)
Contributions of two UDP-glucose dehydrogenases to viability and polymyxin B resistance of Burkholderia cenocepacia
Slade A. Loutet et al.
MICROBIOLOGY-SGM (2009)
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents
Martti Vaara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients
Alexandre P. Zavascki et al.
CLINICAL INFECTIOUS DISEASES (2008)
Risk factors associated with the isolation of colistin-resistant Gyam-negative bacteria: A matched case-control study
Dimitrios K. Matthaiou et al.
CRITICAL CARE MEDICINE (2008)
Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections
Andrea L. H. Kwa et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
Anima Poudyal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance:: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
Phillip J. Bergen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes
Suenje Johanna Pamp et al.
MOLECULAR MICROBIOLOGY (2008)
Capsule polysaccharide is a bacterial decoy for antimicrobial peptides
Enrique Llobet et al.
MICROBIOLOGY-SGM (2008)
The Salmonella PmrAB regulon:: lipopolysaccharide modifications, antimicrobial peptide resistance and more
John S. Gunn
TRENDS IN MICROBIOLOGY (2008)
Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy
Joshua S. Hawley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Alexandre Prehn Zavascki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Semi-synthesis of polymyxin B (2-10) and colistin (2-10) analogs employing the trichloroethoxycarbonyl (Troc) group for side chain protection of α,γ-diaminobutyric acid residues
Keiko Okimura et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2007)
Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro Pharmacokinetic/Pharmacodynamic model
Chun-Hong Tan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Chemical conversion of natural polymyxin B and colistin to their N-terminal derivatives
Keiko Okimura et al.
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN (2007)
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Roxanne J. Owen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Gram-negative outer and inner membrane models: Insertion of cyclic cationic lipopeptides
Adria Clausell et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2007)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The future should not look like the past
[Anonymous]
LANCET INFECTIOUS DISEASES (2006)
A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo
SA Loutet et al.
JOURNAL OF BACTERIOLOGY (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
A formyltransferase required for polymyxin resistance in Escherichia coli and the modification of lipid a with 4-amino-4-deoxy-L-arabinose -: Identification and function of UDP-4-deoxy-4-formamido-L-arabinose
SD Breazeale et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Evaluation of colistin as an agent against multi-resistant in Gram-negative bacteria
J Li et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
The contribution of the N-terminal structure of polymyxin B peptides to antimicrobial and lipopolysaccharide binding activity
N Sakura et al.
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN (2004)
Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa
JB McPhee et al.
MOLECULAR MICROBIOLOGY (2003)
Molecular basis of bacterial outer membrane permeability revisited
H Nikaido
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2003)
Cloning and characterization of the Burkholderia vietnamiensis norM gene encoding a multi-drug efflux protein
CC Fehlner-Gardiner et al.
FEMS MICROBIOLOGY LETTERS (2002)
N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity
H Tsubery et al.
PEPTIDES (2001)
Isolation and structural characterization of colistin components
JA Orwa et al.
JOURNAL OF ANTIBIOTICS (2001)
Isolation and structural characterization of polymyxin B components
JA Orwa et al.
JOURNAL OF CHROMATOGRAPHY A (2001)
Share Paper
